Atractylenolide I

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Atractylenolide-I 通过抑制 TNF-α 和 IL-6 的产生而具有抗炎作用；通过减少促炎细胞因子和 LPS 改善脓毒症综合征、肝肾功能。

Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS. Atractylenolide-I significantly sensitizes the response of MyD88(+) EOC cells to paclitaxel by blocking MD-2-mediated TLR4/MyD88 signaling.

——

——

——

Others

Other Targets

TNF-α| IL-6

Cancer

——

73069-13-3

230.3

C15H18O2

>98% (HPLC)

DMSO : 100 mg/mL 434.22 mM

CC1=C2CC3C(=C)CCCC3(C=C2OC1=O)C

——

(-20℃)

With Ice Pack

≥ 2 years